Matches in Wikidata for { <http://www.wikidata.org/entity/Q65363537> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q65363537 description "clinical trial" @default.
- Q65363537 description "ensayu clínicu" @default.
- Q65363537 description "klinisch onderzoek" @default.
- Q65363537 description "клінічне випробування" @default.
- Q65363537 name "A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)" @default.
- Q65363537 name "A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)" @default.
- Q65363537 type Item @default.
- Q65363537 label "A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)" @default.
- Q65363537 label "A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)" @default.
- Q65363537 prefLabel "A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)" @default.
- Q65363537 prefLabel "A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)" @default.
- Q65363537 P1132 Q65363537-6C696D81-7BFF-4EC4-B076-F11CD2D919CD @default.
- Q65363537 P1476 Q65363537-984BCB9A-885E-4579-A20F-2B8ED7D7DA83 @default.
- Q65363537 P17 Q65363537-1351FF1C-DEE5-4B8D-8535-3F81F54BBB26 @default.
- Q65363537 P17 Q65363537-2EAE7890-3B58-4107-8D53-2DB878D0A79E @default.
- Q65363537 P17 Q65363537-340C4F29-6344-488A-8BEB-46741557989A @default.
- Q65363537 P17 Q65363537-41B825BC-353C-4007-97AD-3995396D561F @default.
- Q65363537 P17 Q65363537-4C6C709B-BC26-47B0-804F-F583671AA94F @default.
- Q65363537 P17 Q65363537-8E7A2237-3441-42BA-8E70-D853152BD5FE @default.
- Q65363537 P17 Q65363537-94F4B099-BCAA-4242-B91E-D0A8B1D4CE62 @default.
- Q65363537 P17 Q65363537-9E4AA6FC-8658-4EDF-8C53-A2546C45E006 @default.
- Q65363537 P17 Q65363537-B2583AE8-CD94-4C7D-AC15-03435EE5D7A9 @default.
- Q65363537 P17 Q65363537-DB58AB64-F3C7-4093-80EC-EEEA787C0895 @default.
- Q65363537 P1813 Q65363537-191BE883-8F1C-4F3E-AAA6-C7B6DDE24988 @default.
- Q65363537 P2899 Q65363537-6BC6B018-7F46-4D30-A161-7E3A22BD460A @default.
- Q65363537 P3098 Q65363537-282A00C8-4F07-41AF-B89B-120E32471145 @default.
- Q65363537 P31 Q65363537-3290483C-50D7-413F-959D-316C20878FC1 @default.
- Q65363537 P580 Q65363537-0F857FB0-9954-4E70-B211-A1B567ABD889 @default.
- Q65363537 P582 Q65363537-8051A3F0-C842-4E8F-AA61-F90FC746748D @default.
- Q65363537 P6099 Q65363537-26726BE1-5882-4A87-A471-55864E6360FD @default.
- Q65363537 P767 Q65363537-AEBC3D62-7526-4545-B41B-D685750773BE @default.
- Q65363537 P8363 Q65363537-41A3E548-EFB1-4F66-8F53-D5BA0030AFA2 @default.
- Q65363537 P1132 "+514" @default.
- Q65363537 P1476 "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Protective Efficacy and Safety of a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)" @default.
- Q65363537 P17 Q142 @default.
- Q65363537 P17 Q16 @default.
- Q65363537 P17 Q17 @default.
- Q65363537 P17 Q183 @default.
- Q65363537 P17 Q29 @default.
- Q65363537 P17 Q30 @default.
- Q65363537 P17 Q31 @default.
- Q65363537 P17 Q34 @default.
- Q65363537 P17 Q408 @default.
- Q65363537 P17 Q865 @default.
- Q65363537 P1813 "HELIOS" @default.
- Q65363537 P2899 "+18" @default.
- Q65363537 P3098 "NCT01877655" @default.
- Q65363537 P31 Q30612 @default.
- Q65363537 P580 "2013-09-11T00:00:00Z" @default.
- Q65363537 P582 "2017-09-28T00:00:00Z" @default.
- Q65363537 P6099 Q42824827 @default.
- Q65363537 P767 Q30283613 @default.
- Q65363537 P8363 Q78089383 @default.